AT03-65 Clinical Trials

1 actively recruiting trial across 1 location

Also known as: AT03-65 Antibody Drug Conjugate

Filter by location:

Portland, Oregon1 trial

FIH Study to Evaluate Safety, Tolerability, PK, PD & Preliminary Efficacy of AT03-65 With Advanced Solid Tumors

Oregon Health & Science University (OHSU)

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.